KEMPHARM, INC 4
4 · KEMPHARM, INC · Filed Jan 31, 2017
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Cohen Daniel L
EVP, Govt and Public Relations
Transactions
- Award
Stock Option (right to buy)
2017-01-27+75,000→ 75,000 totalExercise: $3.55Exp: 2027-01-26→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 27, 2018 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.